Lee Michael Kaplan, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 23 | 2020 | 744 | 3.380 |
Why?
|
| Bariatric Surgery | 24 | 2022 | 887 | 2.970 |
Why?
|
| Weight Loss | 30 | 2019 | 2495 | 2.790 |
Why?
|
| Obesity | 48 | 2022 | 12247 | 2.620 |
Why?
|
| Obesity, Morbid | 17 | 2017 | 1091 | 1.700 |
Why?
|
| Anti-Obesity Agents | 3 | 2022 | 202 | 1.290 |
Why?
|
| Gastrointestinal Tract | 4 | 2017 | 824 | 0.810 |
Why?
|
| Body Weight | 12 | 2020 | 4691 | 0.780 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 1994 | 0.720 |
Why?
|
| Energy Metabolism | 10 | 2018 | 2977 | 0.720 |
Why?
|
| Anastomosis, Roux-en-Y | 3 | 2013 | 78 | 0.670 |
Why?
|
| Social Stigma | 2 | 2020 | 652 | 0.620 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2015 | 44 | 0.570 |
Why?
|
| Duodenum | 3 | 2016 | 473 | 0.560 |
Why?
|
| Liver Diseases | 4 | 2014 | 1254 | 0.530 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2016 | 313 | 0.530 |
Why?
|
| Appetite Depressants | 3 | 2018 | 117 | 0.520 |
Why?
|
| Bile Acids and Salts | 2 | 2014 | 354 | 0.520 |
Why?
|
| Behavior Therapy | 2 | 2019 | 871 | 0.490 |
Why?
|
| Preventive Health Services | 1 | 2019 | 585 | 0.490 |
Why?
|
| Sialyltransferases | 1 | 2013 | 73 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2013 | 374 | 0.480 |
Why?
|
| Blood Glucose | 7 | 2018 | 6296 | 0.450 |
Why?
|
| Medical Records | 1 | 2018 | 1421 | 0.450 |
Why?
|
| Disclosure | 1 | 2018 | 737 | 0.430 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2012 | 126 | 0.430 |
Why?
|
| Postprandial Period | 1 | 2013 | 306 | 0.420 |
Why?
|
| Intestinal Absorption | 2 | 2012 | 431 | 0.420 |
Why?
|
| Energy Intake | 6 | 2017 | 2153 | 0.410 |
Why?
|
| Homeostasis | 5 | 2015 | 3344 | 0.400 |
Why?
|
| Diabetes Mellitus | 4 | 2022 | 5452 | 0.400 |
Why?
|
| Postoperative Period | 5 | 2017 | 1854 | 0.390 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 656 | 0.390 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2010 | 80 | 0.380 |
Why?
|
| Intra-Abdominal Fat | 2 | 2012 | 581 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 2 | 17 | 2021 | 11008 | 0.380 |
Why?
|
| Metagenome | 1 | 2013 | 398 | 0.370 |
Why?
|
| Calcium, Dietary | 1 | 2011 | 524 | 0.350 |
Why?
|
| Gastroenterology | 2 | 2021 | 516 | 0.350 |
Why?
|
| Micronutrients | 1 | 2011 | 369 | 0.350 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 293 | 0.350 |
Why?
|
| Internship and Residency | 2 | 2018 | 5634 | 0.340 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 606 | 0.330 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2017 | 753 | 0.330 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2017 | 413 | 0.330 |
Why?
|
| Diseases in Twins | 1 | 2010 | 463 | 0.330 |
Why?
|
| Insulin Resistance | 5 | 2018 | 3895 | 0.330 |
Why?
|
| Chromosome Aberrations | 3 | 2013 | 1826 | 0.320 |
Why?
|
| Body Mass Index | 18 | 2019 | 12507 | 0.310 |
Why?
|
| Stomach | 1 | 2011 | 674 | 0.310 |
Why?
|
| Endoscopy, Digestive System | 1 | 2009 | 335 | 0.290 |
Why?
|
| Adiposity | 2 | 2013 | 1747 | 0.290 |
Why?
|
| Genome-Wide Association Study | 14 | 2019 | 11951 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2019 | 15600 | 0.290 |
Why?
|
| Intestines | 2 | 2014 | 1932 | 0.280 |
Why?
|
| Eating | 5 | 2013 | 1471 | 0.280 |
Why?
|
| Students, Medical | 1 | 2018 | 1773 | 0.280 |
Why?
|
| Humans | 111 | 2022 | 717237 | 0.270 |
Why?
|
| Referral and Consultation | 1 | 2018 | 3473 | 0.270 |
Why?
|
| Consensus | 5 | 2021 | 2755 | 0.270 |
Why?
|
| Neurofibromatosis 1 | 1 | 2010 | 539 | 0.270 |
Why?
|
| Diet | 7 | 2017 | 7565 | 0.270 |
Why?
|
| Insulin | 4 | 2016 | 6691 | 0.260 |
Why?
|
| Peptide Hormones | 1 | 2005 | 131 | 0.260 |
Why?
|
| Forms and Records Control | 1 | 2005 | 162 | 0.260 |
Why?
|
| Fenfluramine | 2 | 2015 | 63 | 0.240 |
Why?
|
| Male | 66 | 2020 | 351380 | 0.240 |
Why?
|
| Receptors, Opioid, mu | 3 | 2012 | 176 | 0.230 |
Why?
|
| Bacteria | 1 | 2014 | 2098 | 0.230 |
Why?
|
| Glucose | 2 | 2012 | 4303 | 0.230 |
Why?
|
| Hepacivirus | 3 | 1999 | 1321 | 0.230 |
Why?
|
| Benzazepines | 2 | 2018 | 329 | 0.230 |
Why?
|
| Intestine, Small | 1 | 2008 | 1227 | 0.220 |
Why?
|
| Gastrointestinal Diseases | 2 | 2014 | 1160 | 0.220 |
Why?
|
| Motor Activity | 2 | 2011 | 2756 | 0.220 |
Why?
|
| Liver | 6 | 2011 | 7628 | 0.220 |
Why?
|
| Critical Illness | 2 | 2011 | 2543 | 0.220 |
Why?
|
| Glucose Tolerance Test | 3 | 2016 | 1159 | 0.210 |
Why?
|
| Peptides | 6 | 1992 | 4438 | 0.210 |
Why?
|
| Nocardia | 2 | 1991 | 11 | 0.210 |
Why?
|
| Adult | 41 | 2022 | 212451 | 0.210 |
Why?
|
| Hepatitis C | 3 | 1999 | 1518 | 0.210 |
Why?
|
| Preoperative Period | 2 | 2013 | 557 | 0.200 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2010 | 569 | 0.200 |
Why?
|
| Implants, Experimental | 2 | 2012 | 103 | 0.200 |
Why?
|
| Feces | 3 | 2013 | 1382 | 0.190 |
Why?
|
| Endocannabinoids | 1 | 2020 | 98 | 0.190 |
Why?
|
| Middle Aged | 38 | 2019 | 215041 | 0.190 |
Why?
|
| Pituitary Gland, Anterior | 2 | 1990 | 174 | 0.180 |
Why?
|
| Endpoint Determination | 2 | 2013 | 620 | 0.180 |
Why?
|
| Intensive Care Units | 2 | 2011 | 3448 | 0.180 |
Why?
|
| Animals | 32 | 2021 | 170890 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2012 | 8600 | 0.170 |
Why?
|
| Hexokinase | 1 | 1999 | 124 | 0.170 |
Why?
|
| Monitoring, Physiologic | 2 | 2015 | 1762 | 0.170 |
Why?
|
| Female | 57 | 2020 | 377909 | 0.170 |
Why?
|
| Cohort Studies | 12 | 2021 | 39887 | 0.170 |
Why?
|
| Multifactorial Inheritance | 3 | 2019 | 1148 | 0.170 |
Why?
|
| Quantitative Trait Loci | 3 | 2019 | 1979 | 0.170 |
Why?
|
| Calcium | 1 | 2011 | 5832 | 0.170 |
Why?
|
| Proteins | 5 | 1999 | 6166 | 0.170 |
Why?
|
| Interferons | 2 | 1999 | 680 | 0.160 |
Why?
|
| Viral Nonstructural Proteins | 1 | 1999 | 239 | 0.160 |
Why?
|
| Critical Pathways | 1 | 2021 | 459 | 0.160 |
Why?
|
| Vitamin D | 1 | 2011 | 3164 | 0.160 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 533 | 0.160 |
Why?
|
| Comprehensive Health Care | 1 | 2018 | 129 | 0.160 |
Why?
|
| Ghrelin | 3 | 2011 | 259 | 0.160 |
Why?
|
| Kidney | 2 | 2022 | 6910 | 0.150 |
Why?
|
| Peptide Fragments | 3 | 2016 | 5160 | 0.150 |
Why?
|
| Knee Injuries | 1 | 2021 | 472 | 0.150 |
Why?
|
| Rats | 11 | 2012 | 25091 | 0.150 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2019 | 557 | 0.150 |
Why?
|
| Linear Models | 3 | 2013 | 5981 | 0.150 |
Why?
|
| Ribonucleoproteins | 1 | 1999 | 385 | 0.150 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 1 | 2015 | 38 | 0.140 |
Why?
|
| Fatty Liver | 3 | 2014 | 716 | 0.140 |
Why?
|
| RNA, Viral | 3 | 1999 | 2837 | 0.140 |
Why?
|
| Dyslipidemias | 2 | 2015 | 849 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 8 | 2016 | 22929 | 0.130 |
Why?
|
| Gene Expression Profiling | 5 | 2012 | 9532 | 0.130 |
Why?
|
| Health Care Costs | 3 | 2017 | 3179 | 0.130 |
Why?
|
| RNA Polymerase II | 1 | 1999 | 542 | 0.130 |
Why?
|
| Cholesterol, HDL | 4 | 2015 | 1840 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2016 | 23996 | 0.130 |
Why?
|
| Remission Induction | 3 | 2018 | 2391 | 0.130 |
Why?
|
| Leptin | 7 | 2003 | 1580 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2015 | 1578 | 0.130 |
Why?
|
| Cartilage, Articular | 1 | 2021 | 1051 | 0.130 |
Why?
|
| Investigational New Drug Application | 1 | 2013 | 10 | 0.130 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1995 | 99 | 0.130 |
Why?
|
| Cardiac Tamponade | 1 | 1995 | 171 | 0.130 |
Why?
|
| Heterozygote | 2 | 2012 | 2794 | 0.130 |
Why?
|
| Life Style | 3 | 2017 | 3719 | 0.130 |
Why?
|
| Hydrogels | 1 | 2018 | 641 | 0.120 |
Why?
|
| Body Height | 2 | 2010 | 1589 | 0.120 |
Why?
|
| Isoenzymes | 1 | 1999 | 1812 | 0.120 |
Why?
|
| Satiety Response | 1 | 2013 | 51 | 0.120 |
Why?
|
| Hepatitis D | 1 | 1993 | 18 | 0.120 |
Why?
|
| Mitosporic Fungi | 1 | 1992 | 23 | 0.120 |
Why?
|
| Genotype | 7 | 2011 | 12923 | 0.120 |
Why?
|
| Organic Anion Transporters | 1 | 2013 | 90 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 4 | 2020 | 7486 | 0.120 |
Why?
|
| Receptors, LDL | 1 | 2015 | 543 | 0.120 |
Why?
|
| Waist-Hip Ratio | 2 | 2012 | 524 | 0.110 |
Why?
|
| Cryoglobulinemia | 1 | 1992 | 85 | 0.110 |
Why?
|
| Aquaporins | 1 | 2013 | 180 | 0.110 |
Why?
|
| Sodium Chloride | 1 | 2015 | 633 | 0.110 |
Why?
|
| Citrus | 1 | 2011 | 42 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2013 | 142 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 1995 | 341 | 0.110 |
Why?
|
| Hypoglycemic Agents | 4 | 2018 | 2779 | 0.110 |
Why?
|
| Exercise Test | 2 | 1998 | 2119 | 0.110 |
Why?
|
| Pain | 4 | 2012 | 4692 | 0.110 |
Why?
|
| Gene Regulatory Networks | 2 | 2011 | 1730 | 0.110 |
Why?
|
| Mice | 12 | 2020 | 81126 | 0.100 |
Why?
|
| Streptomyces | 1 | 1991 | 94 | 0.100 |
Why?
|
| Pipecolic Acids | 1 | 1991 | 70 | 0.100 |
Why?
|
| Peptide Synthases | 1 | 1991 | 83 | 0.100 |
Why?
|
| Triglycerides | 3 | 2015 | 2591 | 0.100 |
Why?
|
| Food, Formulated | 1 | 2011 | 115 | 0.100 |
Why?
|
| Uracil | 1 | 1991 | 163 | 0.100 |
Why?
|
| Models, Animal | 3 | 2017 | 2220 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 2043 | 0.100 |
Why?
|
| Endocrinology | 1 | 2016 | 414 | 0.100 |
Why?
|
| Genetic Loci | 2 | 2010 | 2614 | 0.100 |
Why?
|
| Food, Fortified | 1 | 2011 | 191 | 0.100 |
Why?
|
| Ephedrine | 1 | 2010 | 50 | 0.100 |
Why?
|
| Probiotics | 1 | 2014 | 342 | 0.100 |
Why?
|
| Treatment Outcome | 10 | 2021 | 62348 | 0.100 |
Why?
|
| Phentermine | 1 | 2010 | 32 | 0.100 |
Why?
|
| Weight Gain | 2 | 2011 | 2209 | 0.100 |
Why?
|
| Diethylstilbestrol | 1 | 1990 | 92 | 0.100 |
Why?
|
| Environment | 2 | 2011 | 1101 | 0.100 |
Why?
|
| Gene Expression Regulation | 8 | 2011 | 12433 | 0.100 |
Why?
|
| Algorithms | 3 | 2017 | 13718 | 0.100 |
Why?
|
| Cyclobutanes | 1 | 2010 | 63 | 0.090 |
Why?
|
| Cholesterol, LDL | 3 | 2015 | 2372 | 0.090 |
Why?
|
| Galanin | 4 | 1991 | 46 | 0.090 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1991 | 210 | 0.090 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 18738 | 0.090 |
Why?
|
| Gastroscopes | 1 | 2009 | 20 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 4 | 1998 | 7074 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2721 | 0.090 |
Why?
|
| Hypotension | 1 | 1995 | 831 | 0.090 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 143 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 1999 | 1923 | 0.090 |
Why?
|
| Analgesia | 2 | 2005 | 479 | 0.090 |
Why?
|
| Thymidine Kinase | 1 | 1989 | 299 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1991 | 633 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2012 | 820 | 0.090 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 178 | 0.090 |
Why?
|
| Surgical Stomas | 1 | 2009 | 45 | 0.090 |
Why?
|
| Lipase | 1 | 2011 | 310 | 0.090 |
Why?
|
| Lymphoma, AIDS-Related | 2 | 2001 | 84 | 0.090 |
Why?
|
| Omentum | 1 | 2009 | 157 | 0.090 |
Why?
|
| Risk Factors | 13 | 2021 | 70864 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2013 | 1692 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2011 | 350 | 0.090 |
Why?
|
| Lung Diseases | 2 | 1998 | 1895 | 0.090 |
Why?
|
| Postoperative Care | 3 | 2016 | 1512 | 0.080 |
Why?
|
| Epidemics | 1 | 2014 | 485 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 473 | 0.080 |
Why?
|
| Injections, Intraperitoneal | 1 | 2008 | 442 | 0.080 |
Why?
|
| Antifungal Agents | 1 | 1992 | 708 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2019 | 17432 | 0.080 |
Why?
|
| Bupropion | 1 | 2010 | 298 | 0.080 |
Why?
|
| Prolactin | 1 | 1990 | 676 | 0.080 |
Why?
|
| Naltrexone | 1 | 2010 | 274 | 0.080 |
Why?
|
| Pituitary Gland | 1 | 1991 | 671 | 0.080 |
Why?
|
| Hepatitis B | 1 | 1993 | 645 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2013 | 798 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 1707 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2016 | 15126 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 778 | 0.080 |
Why?
|
| Gastroscopy | 1 | 2009 | 200 | 0.080 |
Why?
|
| Tacrolimus | 1 | 1991 | 715 | 0.080 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 13612 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2014 | 1568 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1276 | 0.080 |
Why?
|
| Chromosome Mapping | 4 | 2010 | 4825 | 0.080 |
Why?
|
| Lactones | 1 | 2010 | 337 | 0.080 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2019 | 1615 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 642 | 0.080 |
Why?
|
| Marital Status | 1 | 2008 | 441 | 0.080 |
Why?
|
| Base Sequence | 4 | 2010 | 13317 | 0.080 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1991 | 689 | 0.080 |
Why?
|
| Mosaicism | 1 | 2010 | 452 | 0.080 |
Why?
|
| Feeding Behavior | 3 | 2015 | 3198 | 0.080 |
Why?
|
| Jejunum | 1 | 2009 | 503 | 0.080 |
Why?
|
| Sex Characteristics | 4 | 2010 | 2542 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 14243 | 0.080 |
Why?
|
| Double-Blind Method | 4 | 2018 | 11910 | 0.080 |
Why?
|
| Health Planning Guidelines | 1 | 2007 | 165 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2014 | 2088 | 0.070 |
Why?
|